Flat panel computed tomography for non-invasive flow measurement: initial results in in-vitro studies

2007 ◽  
Vol 18 (4) ◽  
pp. 747-752 ◽  
Author(s):  
Andreas H. Mahnken ◽  
Michael Grasruck ◽  
Bernhard Schmidt ◽  
Rolf W. Günther ◽  
Joachim E. Wildberger
1992 ◽  
Vol 16 (4) ◽  
pp. 256-258 ◽  
Author(s):  
Yung-Liang Wan ◽  
Tzong-Jeng Huang ◽  
Dong-Liang Huang ◽  
Tze-Yu Lee ◽  
Chung-Chueng Tsai

2020 ◽  
Vol 11 ◽  
Author(s):  
Ludmilla R. Jorge ◽  
Liliam K. Harada ◽  
Erica C. Silva ◽  
Welida F. Campos ◽  
Fernanda C. Moreli ◽  
...  

Radiology ◽  
1981 ◽  
Vol 138 (2) ◽  
pp. 449-454 ◽  
Author(s):  
J R Haaga ◽  
F Miraldi ◽  
W MacIntyre ◽  
J P LiPuma ◽  
P J Bryan ◽  
...  

Author(s):  
H.W. Deckman ◽  
B.F. Flannery ◽  
J.H. Dunsmuir ◽  
K.D' Amico

We have developed a new X-ray microscope which produces complete three dimensional images of samples. The microscope operates by performing X-ray tomography with unprecedented resolution. Tomography is a non-invasive imaging technique that creates maps of the internal structure of samples from measurement of the attenuation of penetrating radiation. As conventionally practiced in medical Computed Tomography (CT), radiologists produce maps of bone and tissue structure in several planar sections that reveal features with 1mm resolution and 1% contrast. Microtomography extends the capability of CT in several ways. First, the resolution which approaches one micron, is one thousand times higher than that of the medical CT. Second, our approach acquires and analyses the data in a panoramic imaging format that directly produces three-dimensional maps in a series of contiguous stacked planes. Typical maps available today consist of three hundred planar sections each containing 512x512 pixels. Finally, and perhaps of most import scientifically, microtomography using a synchrotron X-ray source, allows us to generate maps of individual element.


2006 ◽  
Vol 15 (04) ◽  
pp. 245-257 ◽  
Author(s):  
H. J. Rolf ◽  
K. G. Wiese ◽  
H. Siggelkow ◽  
H. Schliephake ◽  
G. A. Bubernik

1968 ◽  
Vol 19 (03/04) ◽  
pp. 584-592 ◽  
Author(s):  
Hanna Lukasiewicz ◽  
S Niewiarowski

Summary and Conclusion1. It has been found that EACA does not inhibit activation of human plasminogen into plasmin by SK and UK in a concentration of 5 × 10–2 M. The activation of bovine plasminogen by SK and UK is inhibited by this concentration of EACA but not by a lower one.2. EACA in concentrations of 1,5 × 10–1 – 10–4 M does not inhibit casein proteolysis by plasmin. The proteolysis of fibrinogen and fibrin measured by the release of TCA soluble tyrosine is inhibited by EACA in concentrations of 1,5 × 10–1 – 10–2 M.3. The lysis of non-stabilized clots by plasmin measured in a test tube was inhibited by an EACA concentration of 5 × 10–3 – 5 × 10–4 M. The lysis of stabilized clots by plasmin was inhibited by an EACA concentration of 10–5 M.4. On the basis of experimental findings and data given in literature the authors postulate that the mechanism of the antifibrinolytic effects of EACA consists mainly in a modification of plasmin action on fibrin. These effects are dependent on the structure of the fibrin clots.


Sign in / Sign up

Export Citation Format

Share Document